Purchase price is only the opening bid
Accessories, consumables, training, installation, maintenance and spares can make the quoted price a charmingly incomplete number.
ACCOUNT RESEARCH FOR EYE-CARE DIAGNOSTIC AND SURGICAL EQUIPMENT SELLERS
Reviewed buyer-fit research for equipment suppliers serving eye-care providers—focused on procurement context and measured productive examination workflow, never clinical appropriateness or patient outcomes.
The accounts. The business case. The next move.
Provider equipment procurement and workflow only. Time, utilization and economic value do not establish clinical appropriateness, diagnosis, safety, care quality or patient outcomes. Device labeling, regulation, local protocols and professional judgment remain essential.
THE PAIN / NOT ANOTHER GENERIC LIST
Before selling time becomes sunk time, test the obstacles.
Accessories, consumables, training, installation, maintenance and spares can make the quoted price a charmingly incomplete number.
Without mapping waits and equipment use, a new instrument may sit beside—not solve—the clinic’s actual queue.
More productive examination time is an operational measure, not evidence that extra tests are appropriate or care improved.
WHAT ALMA HUNTER DELIVERS
Compare equipment, accessories, consumables, training, installation, maintenance and service needs—not just the sticker price.
Baseline wait and examination-step times, equipment use and staff time; then retest the same workflow after implementation.
Use time and utilization to inform operations—not to infer test appropriateness, diagnosis, outcomes or care quality.
Illustrative qualification, not a researched account. Unknowns stay unknown.
THE KPIs / TRACK, DO NOT PROMISE
Metrics to monitor—not guaranteed lifts, meetings or sales.
Record baseline and post-change median elapsed minutes for a defined equipment-assisted step; compare like-for-like sessions.
Track occupied operating minutes divided by staffed, available minutes for the selected device and observation period.
Document upfront purchase and first-year ongoing costs, including applicable accessories, service, consumables and training.
THE BUYER’S RETURN FROM YOUR SOLUTION
This models your buyer’s return from your solution—not your revenue from buying leads.
YOUR BUYER’S ROI / FICTIONAL INPUTS
YEAR ONE / USD / MODEL, NOT A FORECAST
Below year-one break-even. Revisit the case—not the arithmetic.
Illustrative, editable assumptions—not validated results, guarantees or Alma service pricing.
Illustrative buyer-side scenario only: estimated gross time value = annual measured exams × estimated time value per exam × realized share. The USD inputs are fictional, not quotes, market benchmarks or promised savings. Replace them with local costed procurement figures and an observed time study. Realized share means the portion of estimated time value actually captured in the specified period; it is not project-success probability. Include upfront plus annual ongoing costs once in year-one cost. Freed time has economic value only if the clinic can use it productively; this calculation does not forecast appointments, revenue, clinical appropriateness, patient outcomes or quality.
Gross benefit = potential units × economic unit value × realized share.
Full year-one cost = full upfront deployment + annual operating cost. Net = benefit − full cost. Year-one ROI = net ÷ full cost × 100. Each cost is subtracted once.
Simple upfront payback = upfront cost ÷ (annual benefit − annual operating cost) × 12 months, only if annual net benefit is positive. It assumes steady annual realization, not a discounted cash-flow forecast. Year-one break-even units = full year-one cost ÷ realized unit value.
The eye-clinic flow article recommends auditing existing patient flow, monitoring waiting times at stations and examining equipment use before making changes. The equipment-procurement article advises budgeting for accessories, spare parts, consumables, maintenance and training alongside purchase price. These sources support measuring workflow and full costs, not a universal time saving or clinical benefit.
These sources explain the economic mechanism and measurement—not Alma Hunter performance:
FROM THE FOUNDER / NOT A CUSTOMER TESTIMONIAL
“Finding companies was never the hard part.”
Scott Hawkyard · Founder, Alma Hunter
A buyer needs a supported business case—not another profile match.
THE NEXT MOVE
Tell us what you sell and who buys it. We agree scope, price and delivery before payment. An inquiry does not start research.
Find my buyersInquiries, support or privacy: sales@almahunter.com
Accounts reviewed against your brief.
Unknowns left visible.